BREAKING: Supreme Court restores access to abortion pill

The Supreme Court was responding to emergency requests filed by Danco and GenBioPro, the companies that make the drugs and profit from the killing of unborn Americans. The 5th Circuit Court of Appeals had granted a request from the state of Louisiana to stop the drug from being prescribed without an in-person meeting between expectant mother and doctor.

Chemical abortions are just one of the ways that women can terminate their pregnancies in the United States, with some states allowing the practice through all nine months of pregnancy. Democrats have sought to make it a common part of what they call "healthcare."

It was under the Biden administration, and following the Supreme Court's ruling on the Dobbs case, overturning the 1970s era Roe v. Wade case, that the drug became prescribed via telehealth and shipped across the country. The Dobbs ruling moved the question of abortion's legality to the state level and many states did away with the practice entirely.

After that decision, then-Attorney General Merrick Garland vowed to make sure that women were still able to access the drug. He said that "The Department of Justice is committed to protecting reproductive freedom. We will continue to use every tool at our disposal to protect women’s access to mifepristone and other lawful reproductive care."

The use of telehealth and the US Postal Service meant that women in states where abortion was illegal could still access the drug and terminate their pregnancies. Mifepristone is an oral tablet that blockes the hormone progesterone and when used with misoprostal it kills an unborn baby up to 10-weeks gestation.

Women who terminated their pregnancies in this way are meant to follow up one or two weeks after ending their pregnancies. In states where abortion is illegal, women seldom follow up with doctors in person to make sure the abortion was fully successful and nothing was left behing in utero that could result in sepsis.

The FDA approved the drug, saying it "is safe when used as indicated and directed and consistent with the Mifepristone Risk Evaluation and Mitigation Strategy (REMS) Program. The FDA approved Mifeprex more than 20 years ago based on a thorough and comprehensive review of the scientific evidence presented and determined that it was safe and effective for its indicated use.

"As of 2016, it is approved for use for medical termination of pregnancy up to 70 days of gestation. The FDA’s periodic reviews of the postmarketing data for Mifeprex and its approved generic have not identified any new safety concerns with the use of mifepristone for medical termination of pregnancy through 70 days gestation. As with all drugs, the FDA continues to closely monitor the postmarketing safety data on mifepristone for the medical termination of pregnancy."

Danco and GenBioPro v. Louisiana by The Post Millennial

https://rumble.com/embed/v771uh0/?pub=2n05b